Salute e Benessere

MAYPHARM CO., LTD. Launches SKINCOLLA: The World's First Recombinant Human…

Revolutionizing Collagen Filler Technology Revolutionizing Collagen Filler Technology SKINCOLLA is a game-changer in aesthetic treatments. It combines 100% human-identical recombinant collagen with Hyaluronic Acid (HA), providing immediate and lasting improvements to skin texture, elasticity, and hydration. This cutting-edge formula mimics the body's natural collagen, restoring firmness, smoothness, and addressing common signs of aging such as wrinkles, sagging, and volume loss. Why...
PR Newswire
14/02/2025

Casino Group: Change in the ownership structure of Infinity Advertising

PRESS RELEASEFebruary 14, 2025 Change in the ownership structure of Infinity AdvertisingFollowing the redefinition of the purchasing alliance between the Casino Group and the Mousquetaires Group in 2024, the two groups are reorganising the ownership structure of their Retail Media subsidiary, Infinity Advertising. The reorganisation sees the Mousquetaires Group become the sole...
Nasdaq GlobeNewswire
14/02/2025

New share-based incentive program for members of management and certain key…

With reference to GN's Remuneration Policy which was approved at the annual general meeting on March 13, 2024 and pursuant to which the long-term incentive program from 2025 onward will be based on performance share units (PSUs) to support performance, retention, and alignment of interest with the company's shareholders, the Board of Directors of GN has adopted the specific terms and conditions of the new PSU plan and made the first grant hereunder. The participants in the PSU plan can be...
Nasdaq GlobeNewswire
14/02/2025

ZINZINO AB (PUBL.): ANNOUNCES ACQUISITION OF ZURVITA'S ASSETS FOLLOWING…

Zurvita operates in the United States, Canada, and Mexico, offering a diverse portfolio of innovative health and wellness products. Through this acquisition, Zinzino will gain access to Zurvita's distribution network, inventory, intellectual property rights, and other key assets. While Zurvita's annual sales currently total approximately USD 30 million, the integration with Zinzino is expected to drive further growth through synergistic benefits, leveraging Zinzino's test-based product approach…
PR Newswire
14/02/2025

Implantica publishes Year-end Report, January - December 2024 (Q4)

Significant events in the fourth quarter Significant events in the fourth quarter Significant events after the end of the period Fourth quarter financial summary Full year financial summary Telephone conference Implantica will hold a teleconference on14 February 2025at 15:00 (CET) withPeter Forsell(CEO), Andreas Öhrnberg (CFO), andNicole Pehrsson(Chief Corporate Affairs Officer). Please see the dial-in details below to join the conference: Webcast:...
PR Newswire
14/02/2025

Augere Medical strengthens its management team

The changes strengthen Augere's ability to focus on commercial activities and strategic objectives Jon H. Hoem will be heading the company as CEO, and he is joined in the management team by Pia H. Smedsrud (Chief Medical Officer), Tor Jan Berstad (Chief Technology Officer), Daniel Mork Engen (QARA Manager), David Borge Larsen (Nordic sales manager), Arne Nilsen (European sales and marketing manager), and Ali Nobakht (Chief Strategy Officer).Even Guttormsen is appointed as the Chair of the...
Nasdaq GlobeNewswire
14/02/2025

Director/PDMR Shareholding

DXS INTERNATIONAL PLC(AQSE: DXSP)Notification of Director / PDMR DealingDXS INTERNATIONAL PLC The Board of DXS International plc (the “Company” or “DXSP), the AQSE Growth Market quoted clinical decision support developer and supplier of clinical decision support systems, has received notification that on 13 February, Mr Bob Sutcliffe, the Chairman, purchased 30,000 Ordinary Shares in the Company at a price of 2.89p per share.Following this transaction Mr Sutcliffe and his...
Nasdaq GlobeNewswire
14/02/2025

Bioretec Ltd's financial statements bulletin 2024: Foundation for future growth…

July–December 2024 in brief July–December 2024 in brief January–December 2024 in brief Key events in 2024 This financial statements bulletin is unaudited. Key figures Alan Donze, CEO of Bioretec Ltd: For Bioretec, year 2024 was a great achievement as we managed to grow our net sales despite the delayed market approvals and significant investment in building out our U.S. infrastructure. We took pivotal strides in the implementation of our strategy. We began our...
PR Newswire
14/02/2025

NIPPON EXPRESS HOLDINGS Completes Procedure to Make Germany's SH HoldCo…

NX Logo: https://kyodonewsprwire.jp/img/202502063911-O3-3GW0nv63 NX Logo:https://kyodonewsprwire.jp/img/202502063911-O3-3GW0nv63 The founder,Dieter Hegele(left), and the President of NXHD,Satoshi Horikiri :https://cdn.kyodonewsprwire.jp/prwfile/release/M103866/202502063911/_prw_PI1fl_Q8fxy492.jpg Headquartered in Karlsruhe,Germany, Simon Hegele is a contract logistics provider founded in 1920 that specializes in providing logistics services for the healthcare industry...
PR Newswire
14/02/2025

Coway Announces Financial Results for Q4 and FY2024

Coway reported the following earnings: Coway reported the following earnings: In 2024, Coway's domestic business recorded a revenue ofKRW 2,581.7 billion, marking an 8.8% increase compared to the previous year. This growth was driven by the strong sales of key products such as water purifiers, air purifiers and bidets, as well as the expanding sales of the high-growth BEREX brand. Coway's overseas subsidiaries reported an annual revenue ofKRW 1,545.2 billionin 2024, showing an 8...
PR Newswire
14/02/2025

Axel Klarmeyer Joins Chamlion as CEO, Chamlion International

"We are delighted to welcome Axel to Chamlion," said Lin Wang, Chairman and Founder of Chamlion. "His deep industry knowledge and proven track record in driving business success in the dental industry, combined with his strategic insight and leadership, will be invaluable as we continue to expand globally." "We are delighted to welcome Axel to Chamlion," saidLin Wang, Chairman and Founder of Chamlion. "His deep industry knowledge and proven track record in…
PR Newswire
14/02/2025

BioVaxys Announces Application for Management Cease Trade Order

While every effort is being made to make the Required Filings as soon as possible, one of the factors contributing to the delay is the recent acquisition of all intellectual property, immunotherapeutics platform Technology, and clinical stage assets of the former IMV Inc. completed on February 16, 2024. The purchase involved the acquisition of 120 patents and it is taking longer than expected for the auditor to complete its review and valuation of the patents. Dale Matheson Carr-Hilton LaBonte…
PR Newswire
14/02/2025

Oculis Announces Pricing of $100 Million Oversubscribed Offering of Ordinary…

The oversubscribed Offering is expected to close on or about February 18, 2025, subject to satisfaction of customary closing conditions. Before closing, the new shares will be issued out of the Company's existing capital band ( Kapitalband ), bringing the total number of registered shares authorized by the Company as per its Articles of Association up to 53,943,700.Oculis intends to use the net proceeds from the Offering to advance and accelerate its clinical development pipeline,...
Nasdaq GlobeNewswire
14/02/2025

Global Artificial Kidney Market to Show Positive Growth at a CAGR of ~13% by…

Key Takeaways from the Artificial Kidney Market Report Key Takeaways from the Artificial Kidney Market Report To read more about the latest highlights related to the artificial kidney market, get a snapshot of the key highlights entailed in theGlobal Artificial Kidney Market Report Artificial Kidney Overview An artificial kidney, also known as a bioartificial kidney or renal replacement device, is a medical device designed to replicate the functions of a natural kidney...
PR Newswire
13/02/2025

Smart Homes Revolution: KNX Home Automation Market Set to Grow at 6.2% CAGR by…

Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-39D12764/Global_KNX_Home_Automation_Market Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-39D12764/Global_KNX_Home_Automation_Market Major Factors Driving the Growth of KNXX Home Automation Market : The KNX Home Automation Market is poised for robust growth as increasing consumer demand for energy-efficient, secure, and integrated home management solutions drives adoption. KNX systems...
PR Newswire
13/02/2025

Press Release: Filing of the 2024 U.S. Form 20-F and French “Document…

Filing of the 2024 U.S. Form 20-F and French “Document d'Enregistrement Universel” containing the Annual Financial ReportParis, February 13, 2025. Sanofi announces today the filing of its Form 20-F with the U.S. Securities and Exchange Commission (SEC) and its “Document d'Enregistrement Universel” containing its Annual Financial Report with the French market regulator Autorité des marchés financiers (AMF).These documents are available on the company's website:https://www.sanofi...
Nasdaq GlobeNewswire
13/02/2025

Global Kratom Extract Market to Expand at 7.8% CAGR | Key Trends & Insights…

Claim Your Free Report: https://reports.valuates.com/request/sample/QYRE-Auto-32D16381/Global_Kratom_Extract_Market Claim Your Free Report:https://reports.valuates.com/request/sample/QYRE-Auto-32D16381/Global_Kratom_Extract_Market Major Factors Driving the Growth of Kratom Extract Market: The Kratom Extract Market is poised for significant growth as consumer interest in natural health supplements and alternative therapies continues to rise. With applications ranging from pain...
PR Newswire
13/02/2025

Acne Drugs Market to Reach USD 4.59 Billion by 2030 | Rising Demand for External…

Claim Your Free Report: https://reports.valuates.com/request/sample/QYRE-Auto-15G7233/Global_Acne_Drugs_Market Claim Your Free Report: https://reports.valuates.com/request/sample/QYRE-Auto-15G7233/Global_Acne_Drugs_Market Major Factors Driving the Growth of Acne Drugs Market: The Acne Drugs Market is poised for robust growth as consumer demand for effective and accessible skincare solutions continues to rise. With acne affecting a wide demographic the market offers a diverse range...
PR Newswire
13/02/2025

Vial Adaptors for Reconstitution Drug Market to Reach USD 4,146.27 by 2032…

Rising Demand for Biologics and Injectable DrugsThe increasing adoption of biologics and injectable drugs is a significant driver for the Vial Adaptors for Reconstitution Drug Market. With the rising prevalence of chronic diseases such as cancer, diabetes, and autoimmune disorders, there is a growing need for biologic therapies that require precise reconstitution before administration. Vial adaptors simplify the preparation process, ensuring accurate drug dosing while minimizing contamination…
PR Newswire
13/02/2025

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as…

Disclosure of Share Capital and Voting Rights Outstandingas of January 31, 2025(Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers)Paris, France (February 13, 2025 - 6:00 pm)– As of January 31, 2025, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks down...
Nasdaq GlobeNewswire
13/02/2025

Ultimovacs ASA: Cancellation of subsequent repair offering

Oslo, 13 February, 2025: Reference is made to the stock exchange announcement published by Ultimovacs ASA ("Ultimovacs" or the "Company") on 17 December 2024 regarding the agreement to combine its business with Zelluna Immunotherapy AS, the fully committed private placement (the "Private Placement"), and the intention to carry out a subsequent repair offering (the "Subsequent Offering"), depending, inter alia, on the development of the price of the shares…
Nasdaq GlobeNewswire
13/02/2025

Remote Patient Monitoring Market to Hit USD 56.94 Billion by 2030 with 12.7%…

Browse in-depth TOC on 'Remote Patient Monitoring Market'400 - Tables50 - Figures400 - Pages Browse in-depth TOC on 'Remote Patient Monitoring Market' 400 - Tables 50 - Figures 400 - Pages Based on indication, the remote patient monitoring market is segmented into oncology, cardiology, neurology, diabetes, sleep disorders, respiratory diseases, wellness improvement, mental health, and others. The cardiology segment holds the largest share of the indication segment market in 2023...
PR Newswire
13/02/2025

Molecular Infectious Disease Testing Market to Hit USD 17.78 Billion by 2029…

Browse in-depth TOC on "Molecular Infectious Disease Testing Market" Browse in-depth TOC on "Molecular Infectious Disease Testing Market" 539 - Tables 61 - Figures 448 - Pages An advancement in multiplex testing which could transform the molecular infectious disease testing market, is the integrated, fully automated multiplex diagnostic platforms. It will combine testing for multiple pathogens in a single reaction with the advantage of full automation, right from sample...
PR Newswire
13/02/2025

Ping An Health Pioneers AI-Driven Healthcare with DeepSeek Integration

As a leading internet healthcare provider in China, Ping An Health has consistently prioritized technological innovation since its inception. By iteratively upgrading its AI capabilities, the Company has built a strong competitive advantage and established comprehensive AI-driven healthcare solutions before, during and after medical consultation. Previously, Ping An Health established five key databases, covering disease, prescription treatment, medical product, medical resource, and personal…
PR Newswire
13/02/2025
Altri  Comunicati